We are live on ! Find out more
Lord, Abbett & Co

Lord, Abbett & Co Portfolio holdings

AUM $30.6B
1-Year Est. Return 57.44%
This Fund
S&P 500
This Quarter Est. Return
-0.65%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$28.1B
AUM Growth
-$3.55B
Cap. Flow
-$2.96B
Cap. Flow %
-10.53%
Top 10 Hldgs %
16.2%
Holding
597
New
82
Increased
154
Reduced
208
Closed
58

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$321M
2
TSLA icon
Tesla
TSLA
+$273M
3
MSFT icon
Microsoft
MSFT
+$159M
4
EVR icon
Evercore
EVR
+$157M
5
ETN icon
Eaton
ETN
+$152M

Sector Composition

Rank Sector Weight
1 Technology 22.47%
2 Financials 14.79%
3 Healthcare 13.99%
4 Industrials 12.34%
5 Consumer Discretionary 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BOH icon
401
Bank of Hawaii
BOH
$3.15B
$4.57M 0.02%
66,284
-258
-0.4% -$18.3K
HPE.PRC
402
Hewlett Packard Enterprise 7.625% Series C Preferred Stock
HPE.PRC
$3.74B
0
LBRT icon
403
Liberty Energy
LBRT
$3.05B
$4.29M 0.02%
270,834
-698,452
-72% -$12.5M
QURE icon
404
uniQure
QURE
$3.03B
$4.25M 0.02%
400,785
+86,372
+27% +$1.21M
JEF icon
405
Jefferies Financial Group
JEF
$12.6B
$4.17M 0.01%
77,805
-13,046
-14% -$886K
DSP icon
406
Viant Technology
DSP
$236M
$4.02M 0.01%
+324,142
New +$5.94M
TWST icon
407
Twist Bioscience
TWST
$5.7B
$3.98M 0.01%
+101,298
New +$4.56M
SLNO
408
DELISTED
Soleno Therapeutics
SLNO
$3.93M 0.01%
+55,061
New +$2.68M
ELVN icon
409
Enliven Therapeutics
ELVN
$3.92B
$3.88M 0.01%
197,279
-188,932
-49% -$4.07M
BIPC icon
410
Brookfield Infrastructure
BIPC
$5.2B
$3.84M 0.01%
106,417
AGYS icon
411
Agilysys
AGYS
$2.97B
$3.81M 0.01%
52,519
-1,115,166
-96% -$102M
PECO icon
412
Phillips Edison & Co
PECO
$5.46B
$3.76M 0.01%
+103,025
New +$3.72M
COIN icon
413
Coinbase
COIN
$38.6B
$3.66M 0.01%
21,242
+1,175
+6% +$284K
IBN icon
414
ICICI Bank
IBN
$108B
$3.6M 0.01%
114,107
-16,032
-12% -$465K
ALC icon
415
Alcon
ALC
$33.6B
$3.58M 0.01%
38,034
+5,637
+17% +$506K
VERA icon
416
Vera Therapeutics
VERA
$2.3B
$3.57M 0.01%
148,530
-1,005,140
-87% -$32.3M
CI icon
417
Cigna
CI
$73.7B
$3.5M 0.01%
10,629
+3,512
+49% +$1.06M
BXC icon
418
BlueLinx
BXC
$422M
$3.47M 0.01%
46,319
-11,081
-19% -$1.03M
UBER icon
419
Uber
UBER
$143B
$3.38M 0.01%
46,419
+15,785
+52% +$1.14M
P
420
Everpure Inc
P
$25.7B
$3.35M 0.01%
75,563
-421,246
-85% -$25.4M
BFLY icon
421
Butterfly Network
BFLY
$1.89B
$3.23M 0.01%
+1,414,475
New +$5.06M
THRM icon
422
Gentherm
THRM
$1.25B
$3.19M 0.01%
119,139
-194,389
-62% -$6.81M
PWR icon
423
Quanta Services
PWR
$100B
$3.1M 0.01%
12,189
-145,981
-92% -$42.2M
SMMT icon
424
Summit Therapeutics
SMMT
$10.4B
$3M 0.01%
+155,514
New +$3.12M
XENE icon
425
Xenon Pharmaceuticals
XENE
$6.06B
$2.95M 0.01%
87,981
-106,990
-55% -$4.06M

Similar funds

Lord, Abbett & Co's Q1 2025 Portfolio in Review

As of Q1 2025, Lord, Abbett & Co held 597 positions worth $28.1B, down 11% from $31.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Lord, Abbett & Co withdrew a net $2.96B in Q1 2025, closing 58 positions and reducing 208 holdings. Its most notable exit was Tesla, an estimated $273M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Lord, Abbett & Co opened a new position in Gilead Sciences worth $167M.

  • Lord, Abbett & Co's largest Q1 2025 buy was Gilead Sciences: 1,491,377 shares worth $167M.
  • Lord, Abbett & Co added most to Meta Platforms (Facebook) in Q1 2025, an estimated $210M increase.
  • Lord, Abbett & Co's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $321M.
  • Lord, Abbett & Co fully exited Tesla in Q1 2025, selling an estimated $273M.
  • Lord, Abbett & Co's ten largest holdings make up 16% of its $28.1B portfolio in Q1 2025.
  • Lord, Abbett & Co opened 82 new positions and closed 58 in Q1 2025.
  • Lord, Abbett & Co's portfolio value fell 11% quarter-over-quarter to $28.1B.

Based on Lord, Abbett & Co's 13F filing for Q1 2025, filed 13 May 2025.